Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642070 · ClinicalTrials.gov registry record
Host Response to Urinary Tract Infection in Women
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 326
- Enrollment target
NCT00642070 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 326 participants.
The verdict
NCT00642070 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 326 participants
- Enrollment target
Study Summary
This study is being done to identify those elements of the immune response that may predispose a woman to recurrent urinary tract infection. We suspect that lesser effectiveness of certain components of the host response will lead to recurrent urinary tract infection. We will also evaluate the role that the bladder reservoir may play in recurrent urinary tract infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00642070
The ClinicalTrials.gov registry entry for NCT00642070 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 326 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00642070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00642070 about?
NCT00642070 is a clinical study titled "Host Response to Urinary Tract Infection in Women". This study is being done to identify those elements of the immune response that may predispose a woman to recurrent urinary tract infection. We suspect that lesser effectiveness of certain components of the host response will lead to recurrent urinary tract infection. We will also evaluate the role ...
What is the current status of trial NCT00642070?
This trial is currently completed. The enrollment target is 326 participants. The study started on 2008-02. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT00642070?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.